Lesayao, Lesalyn T.

HRN: 29-34-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2026
CEFUROXIME 500MG (TAB)
07/30/2026
08/06/2026
PO
500mg
BID X 7 Days
S/P NSVD; Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: